What was already known?Juvenile idiopathic arthritis (JIA) is the name given to inflammation in the joints (arthritis) that first occurs in children and young people under the age of 16. It is a painful and disabling condition that can lead to long-term damage.The...
What was already known? Juvenile idiopathic arthritis (JIA) affects approximately 1 in 1000 children in the UK. Up to one in four of these children will also have serious eye disease associated with their JIA called uveitis. Children with JIA are more likely to...
What was already known? Juvenile idiopathic arthritis (JIA) is a term used to describe a collection of childhood onset arthritic diseases and as such includes a diverse group of diseases. A classification system has been established by the International League of...
What was already known? Biologic therapy is usually given to patients with juvenile idiopathic arthritis (JIA) after they have failed to respond or do not tolerate methotrexate. Patients with systemic JIA do not seem to respond well to tumour necrosis factor...
What was already known? Children and young people with JIA and persistent joint pain and swelling are at risk of disability and joint damage in the long-term. The aim for all these patients is a state of 'clinically inactive disease', in which there is no evidence of...
+44 (0) 161 306 6000
Recent Comments